Literature DB >> 7038976

On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).

O Matsuo, D Collen, M Verstraete.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7038976     DOI： 10.1016/0049-3848(81)90008-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators?

Authors:  W Kasper; T Meinertz; H Just
Journal:  Klin Wochenschr       Date:  1986-04-01

2.  Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

Authors:  W Kasper; T Meinertz; H Wollschläger; T Bonzel; C Chen; T Hofmann; A Zeiher; H Drexler; H Just
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.

Authors:  M L Brochier; L Quilliet; H Kulbertus; P Materne; B Letac; A Cribier; J P Monassier; A Sacrez; J P Favier
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Authors:  M Samama; J Conard; E Verdy; P van Dreden; G Nguyen; A Combrisson; J Acar
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction.

Authors:  J P Monk; R C Heel
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.